newsfilter
← Earnings
Earnings Releases·

West Pharmaceutical Services — Third Quarter 2026 Earnings Summary

West Pharmaceutical Services reported third-quarter 2026 net sales of $874.5 million, representing an 8.7% increase over the prior year period. Diluted earnings per share rose 57.3% to $3.02, while adjusted-diluted EPS increased 35.7% to $2.66. The company raised its full-year 2026 net sales guidance to a range of $3.41 billion to $3.42 billion and adjusted-diluted EPS guidance to $9.38 to $9.48. Additionally, West repurchased $231 million of stock during the quarter and declared a fourth-quarter dividend of $0.26 per share.

Company
WEST PHARMACEUTICAL SERVICES INC
Sector
Healthcare
Industry
Medical Instruments & Supplies